> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# FDA Lifts Greenwich Flamingo-01 Trial Hold
- URL: https://www.fdaweb.com/fda-lifts-greenwich-flamingo-01-trial-hold/
- Published: 2022-07-12T12:00:00.000Z
- Updated: 2026-09-14T17:51:34.000Z
- Author: David McFarland
- Tags: Drugs, #legacy-id-D5152249

FDA has lifted the clinical hold placed on the Greenwich LifeSciences Flamingo-01 Phase 3 clinical trial of the company’s GLSI-100 as a treatment for some invasive breast cancers. Greenwich [says](https://www.businesswire.com/news/home/20220712005542/en/?ref=fdaweb.com) FDA placed the hold due to concerns over manufacturing and the pharmacy process. The statement says discussions between the company and the agency satisfactorily addressed the clinical hold issues and the company has begun site initiation visits.